PriceTargets.com logo

Intelligent Bio Solutions - INBS Stock Price Target and Predictions

  • Consensus Rating: Sell
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 1
  • Breakdown:
  • 1 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$0.75 As of 12/4/2025 05:00 PM ET
▲ +0.0541 (7.81%)

This chart shows the closing price for INBS by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Intelligent Bio Solutions Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for INBS and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for INBS

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 1 analysts offering 12 month price targets for Intelligent Bio Solutions in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $0.75.

This chart shows the closing price for INBS for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Sell

The current consensus among 1 contributing investment analysts is to sell stock in Intelligent Bio Solutions.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/12/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/10/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/9/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/9/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/7/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/5/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings
Ratings as of
11/4/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings
Ratings as of
12/4/2025

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
10/8/2025Weiss RatingsReiterated RatingSell (E+) ➝ Sell (E+)
9/27/2025Weiss RatingsReiterated RatingSell (E+) ➝ Sell (E+)
(Data available from 12/5/2020 forward)

News Sentiment Rating

0.68 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/9/2025
  • 7 very positive mentions
  • 5 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
6/8/2025
  • 4 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/8/2025
  • 4 very positive mentions
  • 9 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/7/2025
  • 3 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/6/2025
  • 1 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/6/2025
  • 1 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/5/2025
  • 2 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/5/2025

Current Sentiment

  • 2 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

Intelligent Bio Solutions logo
Intelligent Bio Solutions Inc., a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.
Read More

Today's Range

Now: $0.75
Low: $0.68
High: $0.76

50 Day Range

MA: $0.90
Low: $0.64
High: $1.17

52 Week Range

Now: $0.75
Low: $0.64
High: $2.75

Volume

197,771 shs

Average Volume

131,529 shs

Market Capitalization

$7.06 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

4.51

Frequently Asked Questions

What sell-side analysts currently cover shares of Intelligent Bio Solutions?

The following Wall Street sell-side analysts have issued reports on Intelligent Bio Solutions in the last twelve months: Wall Street Zen, and Weiss Ratings.
View the latest analyst ratings for INBS.

What is the current price target for Intelligent Bio Solutions?

0 Wall Street analysts have set twelve-month price targets for Intelligent Bio Solutions in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Intelligent Bio Solutions in the next year.
View the latest price targets for INBS.

What is the current consensus analyst rating for Intelligent Bio Solutions?

Intelligent Bio Solutions currently has 1 sell rating from Wall Street analysts. The stock has a consensus analyst rating of "Sell." A "sell" rating indicates that analysts believe INBS will underperform the market and that investors should sell shares of Intelligent Bio Solutions.
View the latest ratings for INBS.

What other companies compete with Intelligent Bio Solutions?

Other companies that are similar to Intelligent Bio Solutions include Retractable Technologies, Envoy Medical, Co-Diagnostics, Predictive Oncology and Vivos Therapeutics. Learn More about companies similar to Intelligent Bio Solutions.

How do I contact Intelligent Bio Solutions' investor relations team?

Intelligent Bio Solutions' physical mailing address is 142 WEST 57TH ST FL11, NEW YORK NY, 10019. The company's listed phone number is 646-828-8258 and its investor relations email address is [email protected]. The official website for Intelligent Bio Solutions is gbs.inc. Learn More about contacing Intelligent Bio Solutions investor relations.